Publications by authors named "S Heijmink"

Purpose To validate a deep learning (DL) model for predicting the risk of prostate cancer (PCa) progression based on MRI and clinical parameters and compare it with established models. Materials and Methods This retrospective study included 1607 MRI scans of 1143 male patients (median age, 64 years; IQR, 59-68 years) undergoing MRI for suspicion of clinically significant PCa (csPCa) (International Society of Urological Pathology grade > 1) between January 2012 and May 2022 who were negative for csPCa at baseline MRI. A DL model was developed using baseline MRI and clinical parameters (age, prostate-specific antigen [PSA] level, PSA density, and prostate volume) to predict the time to PCa progression (defined as csPCa diagnosis at follow-up).

View Article and Find Full Text PDF

: Quality assurance in data collection is essential as data quality directly impacts the accuracy and reliability of outcomes. In the context of early detection of prostate cancer, improving data completeness is a key focus for enhancing patient care. This study aimed to evaluate the effectiveness of a data-driven feedback tool, visualized through a dashboard, in improving the completeness of data collection by healthcare professionals.

View Article and Find Full Text PDF

Objectives: This study investigated patients' acceptance of artificial intelligence (AI) for diagnosing prostate cancer (PCa) on MRI scans and the factors influencing their trust in AI diagnoses.

Materials And Methods: A prospective, multicenter study was conducted between January and November 2023. Patients undergoing prostate MRI were surveyed about their opinions on hypothetical AI assessment of their MRI scans.

View Article and Find Full Text PDF

Background: Dementia-related impairments can cause complex barriers to access, use, and adopt digital health technologies (DHTs). These barriers can contribute to digital health inequities. Therefore, literature-based design principles called DEMIGNED have been developed to support the design and evaluation of DHTs for this rapidly increasing population.

View Article and Find Full Text PDF
Article Synopsis
  • This study assessed the effectiveness of magnetic resonance dispersion imaging (MRDI) in detecting clinically significant prostate cancer (csPCa) compared to standard multiparametric MRI (mpMRI).
  • It involved 76 patients, with two radiologists evaluating MRI results and comparing findings to actual prostate cancer histopathology after surgery.
  • Results indicated that MRDI potentially enhances sensitivity in detecting csPCa and reduces variability between observers, with one radiologist finding a 20% increase in detected cases using MRDI.
View Article and Find Full Text PDF